New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Seagen Inc.
SGEN
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

43B

Biotechnology

Next Earning date - 30 Oct 2024

43B

Biotechnology

Next Earning date - 30 Oct 2024

228.74USD
Shape-0.16 ( -0.07%)
favorite-chart

Relative Strenght

88
favorite-chart

Volume Buzz

1087%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

0%

Quote Panel

Shape
Updated October 23, 2024
1W % 1M % 3M % 1Y 5.19 %

Key Metrics

Shape
  • Market Cap

    43.15B


  • Shares Outstanding

    188.66M


  • Share in Float

    129.83M


  • Dividende

    0


  • Earning Date

    30 Oct 2024


  • Price Target

    228.74


  • Average Volume

    1.63M


  • Beta

    0.321


  • Range

    126.47-228.96


  • Industry

    Biotechnology


  • Website

    https://www.seagen.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

18.76x

P/S Ratio

16.87x

P/B Ratio

0.0

Debt/Equity

-32.6%

Net Margin

$-4.0

EPS

How SGEN compares to sector?

P/E Ratio

Relative Strength

Shape

SGEN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$4B

Shape23%

2025-Revenue

$0.80

Shape145%

2025-EPS

$1B

Shape-23%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

BMO Capital

downgrade

Previous: Outperform

2023-03-14

Now: Market Perform

Raymond James

upgrade

Previous: Outperform

2023-02-16

Now: Strong Buy

Evercore ISI

upgrade

Previous: Not converted

2023-02-16

Now: Outperform

SVB Leerink

downgrade

Previous: Not converted

2023-02-06

Now: Market Perform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.21

arrow
arrow

N/A

-0.95
vs 0.9

Q1.22

arrow
arrow

N/A

-0.74
vs -0.67

Q2.22

arrow
arrow

N/A

-0.73
vs -0.47

Q3.22

arrow
arrow

N/A

-1.03
vs -1.61

Q4.22

arrow
arrow

N/A

-0.80
vs -0.95

Q1.23

arrow
arrow

N/A

-0.93
vs -0.74

Q2.23

arrow
arrow

N/A

-1.13
vs -0.73

Q3.23

arrow
arrow

N/A

-1.15
vs -1.03

Q4.23

arrow
arrow

N/A

-0.88
vs -0.80

Q1.24

arrow
arrow

+123%

0.21
vs -0.93

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.21

arrow
arrow

-29%

429.9M  vs 601.3M

Q1.22

arrow
arrow

+28%

426.5M  vs 332M

Q2.22

arrow
arrow

+28%

497.5M  vs 388.5M

Q3.22

arrow
arrow

+20%

510.3M  vs 424.1M

Q4.22

arrow
arrow

+23%

528.1M  vs 429.9M

Q1.23

arrow
arrow

+22%

519.7M  vs 426.5M

Q2.23

arrow
arrow

+21%

603.8M  vs 497.5M

Q3.23

arrow
arrow

+27%

648.6M  vs 510.3M

Q4.23

arrow
arrow

+30%

687.1M  vs 528.1M

Q1.24

arrow
arrow

+44%

749.5M  vs 519.7M

Return on EquityShape

status-upQoQ

Q4.21

arrow
arrow

-6%

-0.06
vs -0.09

Q1.22

arrow
arrow

-5%

-0.05
vs -0.06

Q2.22

arrow
arrow

-5%

-0.05
vs -0.05

Q3.22

arrow
arrow

-7%

-0.07
vs -0.05

Q4.22

arrow
arrow

-5%

-0.05
vs -0.07

Q1.23

arrow
arrow

-6%

-0.06
vs -0.05

Q2.23

arrow
arrow

-8%

-0.08
vs -0.06

Q3.23

arrow
arrow

-8%

-0.08
vs -0.08

Institutionnal OwnershipShape

status-upQoQ

Q1.22

arrow
arrow

515

515
vs 535

-4%

Q2.22

arrow
arrow

573

573
vs 515

11%

Q3.22

arrow
arrow

578

578
vs 573

1%

Q4.22

arrow
arrow

553

553
vs 578

-4%

Q1.23

arrow
arrow

617

617
vs 553

12%

Q2.23

arrow
arrow

664

664
vs 617

8%

Q3.23

arrow
arrow

695

695
vs 664

5%

Q4.23

arrow
arrow

9

9
vs 695

-99%

Earnings Growth

Latest News

SGEN

businesswire.com

7 hours ago